Decalactone Derivatives from Corynespora cassiicola, an Endophytic Fungus of the Mangrove Plant Laguncularia racemosa by Ebrahim, Weaam et al.
Job/Unit: O20245 /KAP1 Date: 02-05-12 12:46:05 Pages: 10
FULL PAPER
DOI: 10.1002/ejoc.201200245
Decalactone Derivatives from Corynespora cassiicola, an Endophytic Fungus of1
the Mangrove Plant Laguncularia racemosa
Weaam Ebrahim,[a,b] Amal H. Aly,[a] Attila Mándi,[c] Frank Totzke,[d]
Michael H. G. Kubbutat,[d] Victor Wray,[e] Wen-Han Lin,[f] Haofu Dai,[g] Peter Proksch,[a]
Tibor Kurtán,*[c] and Abdessamad Debbab*[a]
Keywords: Natural products / Medicinal chemistry / Drug discovery / Fungi / Structure elucidation / Conformation analy-6
sis / Lactones
Chemical investigation of the ethyl acetate extract of Coryne-
spora cassiicola, isolated from leaf tissues of the Chinese
mangrove medicinal plant Laguncularia racemosa, yielded
four new secondary metabolites, including three decalac-11
tones, xestodecalactones D–F (1–3) as well as corynesidone D
(4), in addition to four known compounds. The structures of
the new compounds were determined on the basis of one-
and two-dimensional NMR spectroscopy as well as by high-
resolution mass spectrometry. Absolute configurations of the16
Introduction
Over the course of the last century, endophytic fungi26
have become a promising source of new natural products
and drug leads that are of great potential for medicinal and
agricultural applications.[1–5] Examples include the potent
antimycotic cryptocandin A,[6] the HIV-1 integrase inhibi-
tors xanthoviridicatins E and F,[7] and Helicobacter pylori31
inhibiting rhizotonic acid.[8] Furthermore, the detection of
several important plant secondary metabolites in endo-
phytic fungal cultures, such as taxol,[9,10] camptothecin,[11]
and podophyllotoxin,[12] suggested their possible use as al-
ternative sources of these metabolites.36
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optically active compounds 1–3 were determined by TDDFT
ECD calculations of their solution conformers, proving that
they belong to the (11S) series of xestodecalactones, opposite
to the (11R) configuration of the known xestodecalactones A–
C. All compounds were tested against a panel of human pro- 21
tein kinases. Among the isolated compounds, two inhibited
several kinases such as IGF1-R and VEGF-R2 with IC50
values mostly in the low micromolar range.
However, due to a reduced hit-rate of novel compounds
from terrestrial endophytic fungi, the focus of drug discov-
ery is shifting more in favor of endophytes from extreme
and less investigated habitats. Such interesting biotopes are
known to influence the fungal secondary metabolites and 41
their respective host plants.[2,4,13,14]
Mangrove forests, constituting a transition zone between
terrestrial and marine habitats, are an example of such an
environment. Plant species inhabiting this particular ecosys-
tem are adapted to frequent and fluctuating environmental 46
changes, including high saline concentrations, adaptation to
low oxygen, nutrient limitation, tidal flushing, high tem-
peratures, excessively high light, drought, and an invigor-
ated microbial community due to warm and damp condi-
tions.[15–17] In this context, endophytic fungi colonizing 51
mangrove plants have been suggested to contribute to their
adaptation to harsh environmental factors,[18] in many cases
by the production of unique functional metabolites,[3,19,20]
which are also of considerable pharmaceutical and thera-
peutic potential.[21] Fungi are well-known to produce a di- 56
verse range of polyketide-derived secondary metabolites,
from simple aromatic rings to complex, highly modified re-
duced-type compounds, such as macrolides.[22,23] This wide
variety of structures is initially formed from poly-β-keto
chains (poly-β-keto esters) biosynthesized through a decar- 61
boxylative condensation of malonyl-CoA units. Aromatic
structures are then rationalized in terms of aldol and
Claisen reactions.[24] The biosynthesis of small macrolides
such as curvularin, which is an octaketide macrolide pro-
duced by some Curvularia,[25] Alternaria,[26] and Penicil- 66
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lium[27] species, is well-studied.[28,29] However, to the best of
our knowledge, the biosynthesis of decalactone and octalac-
tone derivatives has not been investigated.
During our ongoing search for new bioactive metabolites
from plant-derived endophytes,[30–33] we isolated an endo-71
phytic Corynespora cassiicola strain from leaf tissues of the
mangrove plant Laguncularia racemosa (L) Gaertn. (Com-
bretacaeae), collected at Hainan Island in China. L. race-
mosa is an evergreen tree that is common in mangrove for-
ests extending along the Pacific and Atlantic coasts and76
tropical southern Asia.[34] A bark infusion is historically
used as an astringent and tonic, and as a folk remedy for
dysentery, aphthae, fever, and scurvy.[35,36] Morton reported
that the antitumor activity of this plant was attributed to
its tannin content,[37] and its leaves possess antibiotic prop-81
erties against Escherichia coli.[38]
To date, the chemical constituents of fungi belonging to
the genus Corynespora have received scant attention. A lit-
erature survey showed that an endolichenic Corynespora sp.
yielded ten secondary metabolites of polyketide origin: co-86
rynesporol, herbarin, 1-hydroxydehydroherbarin, 9-O-
methylscytalol, scytalol, 7-desmethylherbarin, 8-hy-
droxyherbarin, 8-methylfusarubin, scorpinone, and 8-O-
methylbostrycoidin.[39,40] Furthermore, other metabolites of
depsidone origin, including depsidones A–C and diaryl91
ethers,[41] 6-(3-hydroxybutyl)-7-O-methylspinochrome B,[42]
as well as 2,5,7-trihydroxy-3-methoxynaphthalene-1,4-di-
one[43] were likewise reported from different Corynespora
strains. In the present study, we provide a comprehensive
analysis of natural products produced by Corynespora cassi-96
icola and report on four new, as well as four known, metab-
olites.
Results and Discussions
The crude ethyl acetate extract of Corynespora cassiicola,
cultured on solid rice medium, was taken to dryness and101
then partitioned between n-hexane and 90% methanol. The
90% methanol fraction was purified by chromatography
over different stationary phases (silica gel and Sephadex
LH-20). Final purification by preparative reversed-phase
HPLC afforded eight compounds, the structures of which106
were elucidated by high-resolution ESI mass spectrometry
and NMR spectroscopy. This resulted in the identification
of four new compounds, including three decalactones, xes-
todecalactones D–E (1–3) and the depsidone corynesidone
D (4), together with four known compounds, corynesidone111
A (5) and B (6),[41] 2,5,7-trihydroxy-3-methoxynaphthalene-
1,4-dione (7),[43] and 6-(3-hydroxybutyl)-7-O-methylspin-
ochrome B (8).[42]
Compound 1 was obtained as a yellowish-white amorph-
ous powder. Its molecular formula was determined as116
C15H18O7 on the basis of the [M + H]+ signal detected at
m/z 311.1134 in the HRMS (ESI). Comparison of the
NMR spectroscopic data of 1 with those reported for xesto-
decalactones B and C, previously isolated from Penicillium
cf. montanense,[44] indicated a close structural relationship121
www.eurjoc.org © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 0000, 0–02
between the compounds. However, in comparison to xesto-
decalactones B and C,[44] the 1H NMR spectrum of 1
showed an additional aromatic methoxyl group (δH =
3.68 ppm) and the absence of one aromatic proton Table 1.
Inspection of the COSY correlations (Figure 1) revealed the 126
presence of a continuous spin system from CH2-8 (δH =
3.45 and 2.66 ppm) to 11-CH3 (δH = 1.16 ppm) in analogy
to known xestodecalactones.[44] Moreover, a homonuclear
long-range correlation was observed for CH2-13 (δH =
3.54 ppm) to H-4 (δH = 6.22 ppm), suggesting their neigh- 131
boring positions. The attachment of the methoxyl group to
the aromatic ring at C-2 (δC = 134.1 ppm) was established
on the basis of its HMBC correlation (Figure 2). Moreover,
diagnostic HMBC correlations of CH2-13 to C-4, C-5, C-6
and C-12, as well as of H-4 to C-2, C-3, C-6 and C-13 136
revealed the phenylacetic acid substructure of 1. The ob-
served downfield chemical shift of CH2-8 and its HMBC
correlation to the carbonyl carbon appearing at δC =
204.5 ppm (C-7) indicated its α relationship to C-7. Ad-
ditional correlations were observed for CH2-8 with C-9, 141
CH2-10 (δH = 1.76 and 1.87 ppm) with C-8 and C-9, H-11
(δH = 4.81 ppm) with C-9, and 11-CH3 with C-10 and C-
11, thus establishing the fragment CH2(8)CH(9)
OHCH2(10)CH(11)CH3. The connection of C-7 to the aro-
matic ring was evident from the four-bond long-range ω- 146
correlation of H-4 to C-7. Furthermore, correlation of H-
11 to the ester carbonyl group at δC = 169.1 ppm (C-12)
indicated the linkage between C-12 and the oxygenated
methine group CH-11 through an ester bond.
Figure 1. COSY correlations of the new decalactones.
The relative configuration of 1 was obtained from a care- 151
ful analysis of the coupling constants observed in the well-
resolved 1D 1H NMR spectrum, as well as from ROESY
correlations (1 in Figure 6). The coupling constants of H-8,
9, and 10 were in accord with the lowest-energy computed
conformation. The axial orientation of H-11 was evident 156
from the large 3JH–11ax,H–10ax value (6.7 Hz) showing the
trans diaxial relationships of H-11ax and H-10ax. The three
ROESY correlations of 1 shown in Figure 6 and the cou-
pling constants of H-9ax in dimethyl sulfoxide (DMSO)
(3JH–8ax,H–9ax = 9.4, 3JH–10ax,H–9ax = 6.7 Hz) agree well with 161
Job/Unit: O20245 /KAP1 Date: 02-05-12 12:46:05 Pages: 10
Decalactone Derivatives
Figure 2. Key HMBC correlations of the new decalactones.
the computed conformation, indicating the axial arrange-
ment. For the determination of the absolute configuration,
ECD calculation of the solution conformers and compari-
son with the solution experimental ECD curve were carried
out, which was found previously to be a powerful and reli-166
able tool for this purpose.[45,46] The measured solution ECD
spectrum of 1 exhibited three Cotton effects (CEs) above
225 nm; a negative one at 316 and positive ones at 268 and
238 nm. The initial MMFF conformational search of 1 af-
forded 49 conformers, the DFT reoptimization of which at171
the B3LYP/6-31G (d) level reduced this to three above 1%
population (Figure 3). The three conformers showed minor
differences in the orientation of the phenolic hydroxyl and
methoxyl groups, whereas the fused heterocycle adopted ne-
arly the same conformation. Due to their similar conforma-176
tions, the computed ECD spectra of the individual con-
formers were also quite similar. The Boltzmann-weighted
average ECD spectra of (9R,11R)-1 obtained by various
functionals (B3LYP, BH&HLYP, PBE0) and the TZVP ba-
sis set gave mirror image ECD curves of the experimental181
curve, which allowed the absolute configuration to be deter-
mined as (–)-(9S,11S)-1 (Figure 3). Hence, 1 was identified
as a new natural product for which the name xestodecalac-
tone D was proposed.
Compound 2 was obtained as a yellowish amorphous186
mass. HRMS (ESI) showed a prominent [M + H]+ signal
at m/z 367.1752, indicating a molecular formula of
C19H26O7, with an increase of 56 amu compared to 1. 1H
NMR spectroscopic data of 2 (Table 1) were comparable to
those of 1, thus indicating a structural resemblance between191
both compounds. Common signals were attributed to one
aromatic proton (δH = 6.21 ppm, H-4), a methoxyl group
(δH = 3.69 ppm, 2-OCH3), two aromatic hydroxyl groups
(δH = 9.36 and 9.73 ppm, assigned for 1- and 3-OH, respec-
tively), and a methylene group (δH = 3.46 and 3.78 ppm,196
CH2-13). The COSY spectrum (Figure 1) revealed the pres-
ence of a similar spin system from CH2-8 (δH = 3.04 and
2.93 ppm) to 11-CH3 (δH = 1.10 ppm) as in 1, but lacking
the signal corresponding to 9-OH. Further inspection of
the COSY spectrum indicated an additional spin system ex-201
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Figure 3. Experimental ECD spectrum of 1 in acetonitrile com-
pared with the Boltzmann-weighted BH&HLYP/TZVP spectrum
calculated for the three lowest-energy conformers of (9R,11R)-1.
Bars represent rotatory strength of the lowest-energy conformer.
tending from CH2-1 (δH = 3.41 ppm) to CH3-4 (δH =
0.88 ppm), which was attributed to a n-butyl side chain,
thus accounting for the difference in the molecular weight
between 1 and 2 (56 amu). As in 1, a homonuclear long-
range correlation of CH2-13 to H-4 was detected. The 206
HMBC experiment confirmed the attachment of the meth-
oxyl group at C-2, and established the phenylacetic acid
substructure of 2 by diagnostic correlations of CH2-13 and
H-4 in analogy to 1. Further inspection of the HMBC spec-
trum (Figure 2) corroborated the attachment of CH2-8 to 211
the carbonyl C signal appearing at δC = 204.1 ppm (C-7),
and established the fragment CH2(8)CH(9)CH2(10)CH(11)-
CH3 through correlations of CH2-8 to C-9, CH-9 (δH =
3.68 ppm) to C-1 and C-11, CH2-10 (δH = 1.67 and
1.94 ppm) to C-8 and C-9, H-11 (δH = 4.75 ppm) to C-9, 216
and 11-CH3 to C-10 and C-11. The four-bond long-range
ω-correlation of H-4 to C-7, and the correlation of H-11 to
the ester carbonyl at C-12 (δC = 168.8 ppm) established the
connection of the detected substructures. Moreover, corre-
lation of CH2-1 (δH = 3.41 ppm) to C-9 (δC = 76.1 ppm) 221
indicated that the n-butyl moiety was attached to C-9
through an ether linkage.
Because the coupling constants extracted from 1H NMR
spectrum of 2 and the ROESY correlations (see the Sup-
porting Information, Figure S1) were similar to those of 226
xestodecalactone B,[44] the relative configuration of 2 was
assigned as cis. H-9 and H-11 were found to have an axial
orientation from their large vicinal coupling constants
(3JH–8ax,H–9ax = 10.1 Hz, 3JH–10ax,H–11ax = 11.5 Hz).
Furthermore, a diagnostic ROESY correlation was ob- 231
served for H-9 to H-11, indicating their 1,3-cis orientation
and implying the (9R*,11S*) relative configuration as
shown for 2 in Figure 6. The structures of all the computed
conformers are fully in accordance with the NMR spectro-
scopic data. The solution ECD spectrum of 2 was very sim- 236
ilar to that of (9S,11S)-1. A solution ECD calculation pro-
tocol was pursued on the 9-methoxyl model compound of
2, which revealed that the chiral center was inverted com-
pared to those of (9S,11S)-1. The MMFF conformational
search and DFT optimization provided five major conform- 241
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Table 1. NMR spectroscopic data of xestodecalactone D (1), xestodecalactone E (2), and xestodecalactone F (3).
Position 1[a] 2[b] 3[a]
δC δH δC δH δC δH
1 148.5 149.4 148.7
2 134.1 134.2 133.9
3 151.2 151.5 149.3
4 110.5 6.22, s 110.1 6.21, s 105.7 6.14, s
5 128.6 127.7 130.6
6 120.5 121.7 116.1
7 204.5 204.1 127.8 6.18, d (16.2)
8 52.4 2.66, dd (9.4, 14.6) 60 3.04, dd (10.1, 15.3) 134.3 5.46, dd (9.5, 16.1)
3.45, br. dd (2.2, 14.6) 2.93, br. d (15.1)
9 63.9 4.03, m 76.1 3.68, m 79.9 3.84, ddd (5.1, 9.5, 10.8)
10 41.8 1.76, ddd (6.7, 7.3, 14.6) 52.1 1.67, ddd (9.8, 11.6, 14.6) 42.7 1.77, ddd (10.8, 10.8, 13.8)
1.87, ddd (3.2, 4.0, 14.6) 1.94, br. d (14.6) 2.00, ddd (1.0, 5.1, 13.8)
11 68.2 4.81, ddq (4.0, 6.7, 6.5) 70.9 4.75, ddq (2.6, 11.5, 6.2) 68.6 4.84, ddq (0.9, 10.8, 6.4)
12 169.1 168.8 172.9
13 38.6 3.54, br. s 38.9 3.46, d (18.7) 40.6 3.29[c]
3.78, d (18.7) 3.76, d (15.5)
1 67.1 3.41, m[d] 66.6 3.27, m[c][d]
3.42, m[d]
2 31.5 1.46, m[d] 31.4 1.45, m[d]
3 18.9 1.32, m[d] 18.9 1.30, m[d]
4 13.7 0.88, t (7.3) 13.7 0.86, t (7.4)
2-OCH3 60 3.68, s 60.1 3.69, s 59.8 3.66, s
11-CH3 19.5 1.16, d (6.5) 20.6 1.10, d (6.2) 21.0 1.20, d (6.4)
1-OH 9.32, s 9.36, s 8.65, s
3-OH 9.71, s 9.73, s 9.22, s
9-OH 4.75, d (5.0)
[a] Measured at 600 (1H) and 150 (13C) MHz ([D6]DMSO). [b] Measured at 400 (1H) and 100 (13C) MHz ([D6]DMSO). [c] Overlapped
with water peak. [d] Second order system.
ers above 3% population (Figure S2). H-9 and H-11
adopted pseudo-axial orientation in all conformers, in
which the conformation of the fused heterocycle was practi-
cally the same and differed mainly in the arrangement of
the hydroxyl and methoxyl groups. The Boltzmann-246
weighted TZVP ECD spectra (B3LYP, BH&HLYP, PBE0
functionals) of the conformers of the (9R,11S) enantiomer
reproduced well the experimental ECD curve, with B3LYP
giving the best agreement (Figure 4). Thus, the absolute
configuration of 2 was determined as (+)-(9R,11S) and it251
was named xestodecalactone E. Apparently, the inversion
of the C-9 chirality center did not have a significant effect
on the ECD spectra.
Compound 3 was obtained as a yellowish amorphous
mass. Its molecular formula was determined as C19H26O6,256
on the basis of the [M + Na]+ signal at m/z 373.1618 ob-
tained by HRMS (ESI). 1H NMR spectroscopic data of 3
(Table 1) showed familiar features to those observed for 1
and 2, including one aromatic proton (δH = 6.14 ppm), a
methoxyl group (δH = 3.66 ppm), two aromatic hydroxyl261
groups (δH = 8.65 and 9.22 ppm, assigned for 1- and 3-OH,
respectively), a methylene group (δH = 3.29 and 3.76 ppm,
CH2-13), and signals attributed to the n-butyl side chain
from CH2-1 (δH = 3.27 and 3.42 ppm) to CH3-4 (δH =
0.86 ppm). Inspection of the COSY correlations (Figure 1)266
confirmed the presence of the latter spin system, and
showed the diagnostic homonuclear long-range correlation
of CH2-13 to H-4. They further revealed an additional con-
tinuous spin system from the olefinic CH-7 (δH = 6.18 ppm)
to 11-CH3 (δH = 1.20 ppm). By analogy to 1 and 2, the271
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Figure 4. Experimental ECD spectrum of 2 in acetonitrile com-
pared to the Boltzmann-weighted B3LYP/TZVP spectrum calcu-
lated for the five lowest-energy conformers of the truncated model
of the (9R,11S)-enantiomer. Bars represent rotatory strength of the
lowest-energy conformer.
HMBC experiment corroborated the attachment of the
methoxyl group at C-2, the phenylacetic acid substructure
of 3, the ester bond linkage between C-12 (δC = 172.9 ppm)
and the oxygenated methine group at C-11 (δH = 4.84 ppm),
as well as the attachment of the n-butyl side chain to C-9 276
(δC = 79.9 ppm) through an ether linkage (Figure 2). Fur-
ther inspection of the HMBC spectrum indicated corre-
lations of CH-7 (δH = 6.18 ppm) with C-1, C-5, C-6 and C-
8, CH-8 (δH = 5.46 ppm) with C-7 and C-9, CH-9 (δH =
3.84 ppm) with C-1, C-7 and C-10, CH2-10 (δH = 1.77 and 281
2.00 ppm) with C-8 and C-9, CH-11 (δH = 4.84 ppm) with
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C-9, and 11-CH3 with C-10 and C-11. Accordingly, the
fragment CH(7)CH(8)CH(9)CH2(10)CH(11)CH3 was es-
tablished, indicating a possible reduction of the C-7–C-8
bond in 2 followed by dehydration at the same bond. At-286
tachment to the aromatic ring at C-6 was deduced from
correlations of CH-7 to C-6 and C-1 and C-5.
As with 1 and 2, the relative configuration of 3 was deter-
mined from an analysis of the coupling constants and
ROESY correlations. The axial orientations of protons H-291
9 and H-11 were evident from their large 3J values (3JH–
8ax,H–9ax = 9.5 Hz, 3JH–10ax,H–11ax = 10.8 Hz). Moreover, H-
9 showed a diagnostic through-space correlation with H-11,
which is an indication of the cis orientation of H-9 and H-
11 as found in 2. In addition, the 1,3-cis diaxial relationship296
of H-9 and H-11 was found in all of the four computed
low-energy conformers. The experimental ECD spectrum of
3 was completely different to those of 1 and 2 due to a
different chromophore system. There were three negative
CEs at 287, 250 and 216 nm and the 316 nm band was miss-301
ing. The MMFF conformational search and DFT reoptimi-
zation of the 9-OMe model compound afforded four major
conformers above 2% populations (see the Supporting In-
formation, Figure S3). The Boltzmann-weighted ECD spec-
tra of the (9R,11S) model compound showed good agree-306
ment with the experimental solution ECD curve (Figure 5),
which proved that 3 is homochiral with 2, i.e., it has (–)-
(9R,11S) absolute configuration. Compound 3 was hence
identified as a new natural product for which the name xes-
todecalactone F was proposed. The new optically active311
natural products 1–3 have the same (11S) absolute configu-
ration, and their stereochemistry differed in the configura-
tion of the C-9 chiral center. The ECD spectra of 1 and 2
are mirror images compared to those of the related xestode-
calactones A–C, which confirms that the former belong to316
the (11S) series, whereas the latter belong to the (11R)
series. A similar phenomenon has recently been found for
curvularin derivatives; most curvularin-type natural prod-
ucts belong to the (15S) series, but (15R) derivatives have
also been recently reported.[47,48]321
Only 1 showed a trans configuration of H-9 and H-11,
whereas 2 and 3 showed a cis relationship (Figure 6). How-
ever, the cis-isomer of 1 (1a) was also detected, albeit as a
mixture with 1. Upon measuring the ROESY spectrum of
the mixture of both isomers, a clear cross-peak between H-326
9 and H-11 was observed only for the cis isomer 1a. This
Figure 6. Key ROESY correlations of the new decalactones.
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Figure 5. Experimental ECD spectrum of 3 in acetonitrile com-
pared with the Boltzmann-weighted PBE0/TZVP spectrum calcu-
lated for the four lowest-energy conformers of the truncated model
compound of the (9R,11S)-enantiomer. Bars represent rotatory
strength of the lowest-energy conformer.
indicates the presence of both stereoisomers, as described
previously for other derivatives,[44] however, the low
amounts of the fraction available (ca. 0.9 mg) did not per-
mit purification of the cis isomer 1a. 331
Compound 4 was obtained as a grey amorphous powder
with a molecular formula of C15H12O6, deduced from the
[M + H]+ signal at m/z 289.0712 in the HRMS (ESI), thus
revealing an increase in the molecular weight by 16 amu
compared to the known corynesidone A (5), which was like- 336
wise isolated from Corynespora cassiicola.[41] The 1H NMR
spectra of both compounds were very similar, except for
the presence of only one pair of meta-coupled protons in 4
(Table 2) instead of the two pairs in 5. This was further
confirmed by inspection of the COSY spectrum, which 341
showed only one spin system composed of H-9, H-7 and
CH3-13. The aromatic proton appeared as a singlet at δH
= 6.68 ppm (H-4) and showed a ω-correlation to the ester
carbonyl group at δC = 163.6 ppm (C-11), and no corre-
lation to the methyl group (CH3-12, δH = 2.25 ppm, δC = 346
13.6 ppm) neither in the COSY nor in the HMBC spectra.
On the other hand, the HMBC spectrum showed strong
correlations (3J) of both H-4 and CH3-12 to C-11a (δC =
113.6 ppm) and the oxygenated C-2 (δC = 142.4 ppm).
Thus, the 16 amu increase in molecular weight, correspond- 351
ing to an additional oxygen atom in the structure of 4 com-
pared to 5, and the downfield chemical shift of C-2, re-
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vealed the presence of an additional hydroxyl group at C-
2. Hence, 4 was identified as a new natural product and was
given the name corynesidone D.356
Table 2. NMR spectroscopic data of corynesidone D (4). Measured
at 400 (1H) and 100 (13C) MHz ([D6]acetone).
Position 4
δC δH HMBC
1 128.6
2 142.4
3 150.5
4 105.0 6.68, s 2, 3, 4a, 11, 11a
4a 156.6
5a 143.8
6 131.8
7 114.2 6.45, d (2.0) 5a, 8, 9, 13
8 155.2
9 105.7 6.45, d (2.0) 5a, 7, 8, 9a
9a 146.0
11 163.6
11a 113.6
12 13.6 2.25, s 1, 2, 11a
13 16.0 2.26, s 5a, 6, 7
Compound 8 was obtained as a red-brown solid. MS and
1H NMR (Table 3) data resembled those previously re-
ported for 6-(3-hydroxybutyl)-7-O-methylspinochrome B,
isolated from Fungi imperfecti.[42] The structure was con-
firmed by inspection of COSY and HMBC spectra361
(Table 3). Although previously isolated, no attempts were
made to determine the absolute stereochemistry of 8.
Hence, the modified Mosher procedure[49] was applied to
determine the absolute configuration of the chiral center C-
3. The observed chemical shift differences (500 MHz,366
C5D5N) between the (2S)-2-methoxy-2-trifluoromethyl-
2-phenylacetic acid (MTPA) ester and its (2R)-MTPA dia-
stereomer (Table 4) were consistent with the (3R) absolute
configuration of 8.
The isolated compounds were subjected to a panel of371
bioassays to evaluate their potential activities. These in-
cluded an estimation of their cytotoxic activity against mu-
rine L5178Y cells and antibacterial activity against multi
drug resistant strains of Staphylococcus aureus, Streptococ-
cus pneumoniae, Enterococcus faecium, and Enterococcus376
cloacae. In addition, antifungal activity of the isolated com-
pounds against drug resistant strains of Aspergillus fumi-
gatus, Aspergillus faecalis, Candida albicans, and Candida
Table 5. IC50 values of compounds 6 and 8 against different protein kinases.[a].
AKT1 ALK ARK5 Aurora-B AXL FAK IGF1-R MEK1 wt
6 5.28E-05 4.26 E-06 4.92 E-05 1.57 E-06 9.13 E-06 2.21 E-05 4.87 E-06  1 E-04
8 7.18 E-05 5.65 E-06 6.96 E-05 2.83 E-05 9.15 E-06 1.73 E-05 3.51 E-06  1 E-04
MET wt NEK2 NEK6 PIM1 PLK1 PRK1 SRC VEGF-R2
6 8.15 E-06 5.22 E-05 2.34 E-05 3.52 E-07 2.79 E-05 4.90 E-05 3.56 E-06 5.12 E-06
8 1.69 E-05 6.46 E-05 4.17 E-05 2.54 E-06  1 E-04 9.89 E-05 2.39 E-06 4.48 E-06
[a] Inhibitory potentials of compounds at various concentrations were determined in biochemical protein kinase activity assays. Listed
are IC50 values in mol/L.
www.eurjoc.org © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 0000, 0–06
Table 3. NMR spectroscopic data of 8 at 600 (1H) and 150 (13C)
MHz ([D6]DMSO) and 6-(3-hydroxybutyl)-7-O-methylspinoch-
rome B (8).
Position 8 8
δC δH HMBC δH
1 181.2
2 161.1
3 147.7
4 185.7
4a 105.8
5 160.9
6 122.3
7 140.4
8 107.3 7.04, s 6a, 7, 9, 10 7.06, s
8a 128.6
1 19.2 2.65, m 5, 6, 2, 3 2.65, t (6)
2.63[a] 5, 6, 2, 3 2.65, t (6)
2 38.9 1.51, m 1, 3,4 1.50, m
1.49, m 1,3,4 1.50, m
3 66.1 3.60, m 1 3.50, m
4 23.4 1.09, d (6.3) 2, 3 1.10, d (6)
7-OMe 60.3 3.78, s 7 3.85, s
OH-5 12.61, s 5, 6, 4a 12.65, s
[a] Overlapped by the solvent peak.
Table 4. Chemical shift difference between the (S)-MTPA and (R)-
MTPA esters of 8.
H atom Chemical shift (δH, in C5D5N, at 500 MHz) Δ δS – δR
8 (S)-MTPA ester (R)-MTPA ester
1 3.31 2.27 2.33 –0.04
2 2.16 1.61 1.90 –0.29
4 1.40 1.30 1.28 +0.02
krusei was investigated, as well as their antitrypanosomal
activity. None of the isolated natural products proved to be 381
active in any of the cellular screens applied. However, in a
biochemical protein kinase activity assay using 16 different
human protein kinases, 6 and 8 inhibited several of the
tested kinases (Table 5). The IC50 values observed for both
compounds were in the low micromolar range against some 386
protein kinases such as ALK, VEGF-R2, SRC, IGF1-R,
and PIM1 of which inhibition is known to confer antitu-
moral effects. Of special interest is the fact that 6 inhibited
PIM1with an IC50 value of 3.510–7 m, indicating a tenfold
higher specificity of this naturally occurring inhibitor 391
against this particular protein kinase in comparison to most
of the other kinases investigated in this study (Table 5).
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Conclusion
The structures of three new xestodecalactones DˆF and a
new corynesidone D have been determined through the use396
of 1D and 2D NMR spectroscopic techniques and mass
analysis. Scheme 1 summarizes the deduced structures. 
((=Authors: this short conclusion has been added. Please
check and extend if desired)) 
Scheme 1. Structures of isolated compounds.
Experimental Section401
General Experimental Procedures: Optical rotation values were
measured with a Perkin–Elmer-241 MC polarimeter. 1D and 2D
NMR spectra were recorded with Bruker ARX 500, ARX 400, or
AVANCE DMX 600 NMR spectrometers. MS (ESI) and HRMS
(ESI) were obtained with Finnigan LCQ Deca and Micromass406
QTOF 2 mass spectrometers, respectively. Solvents were distilled
prior to use, and spectral grade solvents were used for spectroscopic
measurements. HPLC analysis was carried out with a Dionex P580
HPLC system coupled to a photodiode array detector (UVD340S).
Routine detection was performed at 235, 254, 280, and 340 nm.411
The separation column (1254 mm, L i.d.) was prefilled with
Eurospher-10 C18 (Knauer, Germany), and the following gradient
was used (MeOH/0.02% H3PO4 in water); 0 min, 10% MeOH;
5 min, 10% MeOH; 35 min, 100% MeOH; 45 min, 100% MeOH.
Fungal Material: Fresh, healthy leaves of Languncularia racemosa416
(Combretacaeae) were collected in September 2009 from Hainan
Island, China. Leaves were rinsed twice with sterilized distilled
water. Surface sterilization was achieved by immersing the leaves in
70% ethanol for 2 min (twice) followed by rinsing twice in sterilized
distilled water. The leaves were then cleaved aseptically into small421
segments (ca. 1 cm in length). The material was placed on a Petri
Eur. J. Org. Chem. 0000, 0–0 © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.eurjoc.org 7
dish (malt agar medium) containing an antibiotic to suppress bac-
terial growth (medium composition: 15 g/L malt extract, 15 g/L
agar, and 0.2 g/L chloramphenicol in distilled water, pH 7.4–7.8)
and incubated at room temperature (25 °C). After several days, hy- 426
phae growing from the plant material were transferred to fresh
plates with the same medium, incubated again for 10 d, and period-
ically checked for culture purity.
Identification of Fungal Cultures: Fungal cultures were identified
according to a molecular biological protocol by DNA amplifi- 431
cation and sequencing of the ITS region as described previously.[50]
The sequence data have been submitted to GenBank, accession
number HQ389223. The fungal strain was identified as Corynes-
pora cassiicola. A voucher strain (strain designation JCM 23.3) is
kept in the Institute of Pharmaceutical Biology and Biotechnology, 436
Düsseldorf, Germany.
Cultivation: Twenty Erlenmeyer flasks (1 L each) containing 100 g
of rice and 100 mL of distilled water were autoclaved. A small part
of the medium from a Petri dish containing the purified fungus was
transferred under sterile conditions to the rice medium. The fungal 441
strain was grown on solid rice medium at room temperature (22 °C)
for 40 d.
Extraction and Fractionation: The culture was extracted extensively
with EtOAc. The EtOAc extract was washed with water, taken to
dryness, and partitioned between n-hexane and 90% MeOH. The 446
90% MeOH fraction was purified by chromatography over silica
gel F254 (Merck, Darmstadt, Germany) using gradient elution (n-
hexane/EtOAc/CH2Cl2/MeOH). One of the resulting fractions
(MeOH/CH2Cl2, 60:40) was purified by chromatography over a Se-
phadex LH-20 column with 100% MeOH as solvent. Based on 451
detection by TLC (silica gel F254, Merck, Darmstadt, Germany)
using EtOAc/MeOH/H2O (77:13:10) as solvent system, collected
fractions were combined and subjected to semipreparative HPLC
(Merck, Hitachi L-7100) using a Eurosphere 100–10 C18 column
(3008 mm, L i.d.) with the following gradient (MeOH/H2O): 456
0 min, 10% MeOH; 5 min, 10% MeOH; 35 min 100% MeOH;
45 min, 100% MeOH. Yields of compounds were as follows:
2.1 mg (1), 2.2 mg (2), 2 mg (3), 3.4 mg (4), 2.2 mg (5), 19.4 mg (6),
1.8 mg (7), 49.2 mg (8).
Xestodecalactone D (1): Yield 2.1 mg; yellowish white amorphous 461
powder; [α]D20 = –25 (c 0.04, CHCl3). UV (PDA): λmax = 202.2,
222.5, 275.5 nm; ECD (CH3CN, c = 1.12 10–3): λmax (Δε) = 316
(–3.73), 268 (3.31), 238 (3.19), 219 (–0.39), 207 (0.36), 192
(–4.11) nm; 1H and 13C in [D6]DMSO, see Table 1. MS (ESI+): m/z
= 311.0 [M + H]+, 333.0 [M + Na]+; MS (ESI–): m/z = 309.0 [M – 466
H]–; HRMS (ESI): calcd. for C15H19O7 [M + H]+ 311.1131; found
311.1134.
Xestodecalactone E (2): Yield 2.2 mg; yellowish amorphous mass;
[α]D20 = +12 (c = 0.115, CHCl3); UV (PDA): λmax = 220.9, 252.5 nm;
ECD (CH3CN, c = 2.05 10–3): λmax (Δε) = 313 (–3.34), 264 (3.41), 471
236 (2.96), 207 (1.03), 192 (–3.05) nm; 1H and 13C in [D6]DMSO,
see Table 1. MS (ESI+): m/z = 366.9 [M + H]+, 754.7 [2M +
Na]+; MS (ESI–): m/z = 365.0 [M – H]–; HRMS (ESI): calcd. for
C19H26O7 [M + H]+ 367.1751; found 367.1752.
Xestodecalactone F (3): Yield 2.0 mg; yellowish amorphous mass; 476
[α]D20 = –180 (c = 0.04, CHCl3). UV (PDA): λmax = 202.8, 221.8,
274.8 nm; ECD (CH3CN, c = 0.85 10–3): λmax (Δε) = 287 (sh,
–2.23), 250 (–11.65), 216 (–18.09), positive below 198 nm. 1H and
13C in [D6]DMSO, see Table 1. MS (ESI+): m/z = 722.0 [2M +
Na]+; MS (ESI–): m/z = 349.0 [M – H]–; HRMS (ESI): calcd. for 481
C19H26O6 [M + Na]+ 373.1627; found 373.1618.
Corynesidone D (4): Yield 3.4 mg; grey amorphous powder; UV
(PDA): λmax = 230.7, 271.7 nm; 1H and 13C in [D6]acetone, see
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Table 2. MS (ESI+): m/z = 289.1 [M + H]+, 598.8 [2M + Na]+,
886.5 [3M + Na]+; MS (ESI–): m/z = 287.1 [M – H]–; HRMS (ESI):486
calcd. for C15H13O6 [M + H]+ 289.0712; found 289.0712.
6-(3-Hydroxybutyl)-7-O-methylspinochrome B (8): Yield 49.2 mg;
red-brown solid; [α]D20 = –12 (c = 0.025, acetone); UV (PDA) λmax
= 213.7, 268.0, 320.7 nm; 1H and 13C in [D6]DMSO (Table 3), MS
(ESI+): m/z = 309.1 [M + H]+, 331.0 [M + Na]+; MS (ESI–): m/z491
= 307.1 [M – H]–.
Mosher Method: The reaction was performed according to a conve-
nient Mosher ester procedure.[49]
Biochemical Protein Kinase Activity Assay: Protein kinase inhibi-
tory activity was determined in 96-well plates as described pre-496
viously.[51] The following substrates were used: GSK3(14–27),
AKT1, NEK6, PIM1; tetra(LRRWSLG), Aurora B; poly(Glu,Tyr)
4:1, FAK, IGF1-R, SRC, VEGF-R2; poly(Ala,Glu,Lys,Tyr)6:2:5:1,
ALK, AXL, METwt; ERK2-KR, MEK1 wt; Rb-CTF, NEK2;
RBER-CHKtide, PLK1, PRK1. Autophosphorylation was mea-501
sured for ARK5.
Computational Section: Conformational searches were carried out
by using Macromodel 9.7.211[52] software employing the Merck
Molecular Force Field (MMFF) with implicit solvent model for
chloroform. Geometry reoptimizations at the B3LYP/6-31G(d)506
level of theory followed by TDDFT calculations using various
functionals (B3LYP, BH&HLYP, PBE0) and TZVP basis set were
performed by the Gaussian 03[53] package. Boltzmann distributions
were estimated from the ZPVE corrected B3LYP/6-31G(d) energies.
ECD spectra were generated as the sum of Gaussians[54] with 3000511
and 2100 cm–1 half-height width (corresponding to ca. 19 and
13 nm at 250 nm, respectively), using dipole-velocity computed ro-
tational strengths for conformers above 3%. The MOLEKEL[55]
software package was used for visualization of the results.
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ture elucidation / Conformation analysis /676
Lactones
Three new xestodecalactones DˆF (1–3) and spectrometry. The absolute configurations
a new corynesidone D were isolated from of 1–3 were determined by TDDFT ECD
Corynespora cassiicola. The structures were calculations. All compounds were tested
determined by 1D and 2D NMR spec-681 against a panel of human protein kinases.
troscopy as well as by high-resolution mass
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